NMS Group pushes oncology forward.
We are a solid partner, ensuring transparency and exceeding standards.
We gain our reliability from building genuine relationships that are based on trust.
We have a flexible approach to challenges.
Our modular structure enables us to look at the bigger picture and nurture a dynamic mindset, as well as an ability to adapt to changes. We are a tight community of capable visionaries from the Nerviano campus. We’re open-minded, resourceful and enthusiastic to face and embrace every single assignment ahead.
We push oncology forward.
Whatever it takes.
- Italy’s largest medicine center
- Europe’s largest anti-cancer drugs innovation R&D center
- One of the world’s largest kinase research platforms
- Global leading original innovative R&D company
- 8 products listed successfully; 9 projects out licensed or in collaboration with international partners, 13 projects in pipelines
- More than 1,400 patents and more than 310 articles published
400 plus employees, 80% with over 10 years of working experience, 44% with over 20 years
Pre-clinical research studies per year
Overall collaborations with clinical centers around the world
studies per year
with clinical centers
around the world